GALVmed aims to make a significant contribution towards transformational change in the smallholder livestock health landscape by developing a portfolio of high impact products and initiating a range of private sector market initiatives operating at scale in the smallholder sector.
About GALVmed
Ten products have been delivered in the past decade.
Proof of concepts achieved for eight products.
A significant increase in scope and scale over a relatively short period.
The estimated value of livestock disease mortalities that has been averted is USD 167 million.
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
In parts of India, rural women are vital in delivering animal health products to smallholder farmers who need them. These women are locally referred to as Pashu Sakhis loosely translated as friends of the animals. …
To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, recently conducted a weeklong livestock …
In July 2018, GALVmed’s partner Boehringer Ingelheim launched a new project known as The Last Mile Initiative. The project is designed to address weak distribution channels and help smallholder farmers in Africa increase their …
